Antibiofilm and Anti-Candidal Activities of the Extract of the Marine Sponge Agelas dispar

Mycopathologia. 2021 Dec;186(6):819-832. doi: 10.1007/s11046-021-00591-9. Epub 2021 Sep 26.

Abstract

This study aimed to determine the antifungal and antibiofilm activities of Agelas dispar on biofilm-producing Candida species. The methanolic extract of A. dispar was obtained and the fraction Ag2 showed inhibitory activity for all 13 Candida strains tested, in concentrations ranging from 2.5 to 0.15625 mg/mL. Antifungal activity of fungicidal nature was seen between 5.0 and 0.3125 mg/mL of extract against the strains. All the strains were classified as biofilm producers. The methanolic extract Ag2 was tested at concentrations of 2.5 and 1.25 mg/mL for antibiofilm activity against the biofilm formation and maturation in all the strains of the genus Candida. Treated and untreated biofilm samples were selected for visualization using scanning electron microscopy (SEM). SEM allowed the visualization of the quantitative decrease in the microbial community, alterations of structural morphology, and destruction of both the formation and maturation of biofilms, at the cellular level. The mechanism of action of this fraction is suggested to be at the plasma membrane and/or cell wall alteration level. Therefore, the use of the methanolic extract of A. dispar may be a promising antifungal and antibiofilm therapeutic strategy against different species of the genus Candida.

Keywords: Antimicrobials; Biofilms; Candida species; Marine sponge.

MeSH terms

  • Agelas*
  • Animals
  • Antifungal Agents / pharmacology
  • Biofilms
  • Candida
  • Candida albicans
  • Microbial Sensitivity Tests
  • Plant Extracts / pharmacology
  • Porifera*

Substances

  • Antifungal Agents
  • Plant Extracts